These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1021 related articles for article (PubMed ID: 14621276)

  • 21. Perceptions of gastroenterologists and patients regarding irritable bowel syndrome and inflammatory bowel disease.
    Levy S; Segev M; Reicher-Atir R; Steinmetz A; Horev N; Niv Y; Dickman R
    Eur J Gastroenterol Hepatol; 2014 Jan; 26(1):40-6. PubMed ID: 24025978
    [TBL] [Abstract][Full Text] [Related]  

  • 22. EHealth: self-management in inflammatory bowel disease and in irritable bowel syndrome using novel constant-care web applications. EHealth by constant-care in IBD and IBS.
    Pedersen N
    Dan Med J; 2015 Dec; 62(12):B5168. PubMed ID: 26621403
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The visceral sensitivity index: A novel tool for measuring GI-symptom-specific anxiety in inflammatory bowel disease.
    Trieschmann K; Chang L; Park S; Naliboff B; Joshi S; Labus JS; Sauk JS; Limketkai BN; Mayer EA
    Neurogastroenterol Motil; 2022 Sep; 34(9):e14384. PubMed ID: 35478469
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Quality of life in patients with inflammatory bowel disease and irritable bowel syndrome differs between subjects recruited from clinic or the internet.
    Jones MP; Bratten J; Keefer L
    Am J Gastroenterol; 2007 Oct; 102(10):2232-7. PubMed ID: 17680842
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Anhedonia in irritable bowel syndrome and in inflammatory bowel diseases and its relationship with abdominal pain.
    Carpinelli L; Bucci C; Santonicola A; Zingone F; Ciacci C; Iovino P
    Neurogastroenterol Motil; 2019 Mar; 31(3):e13531. PubMed ID: 30628137
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Perceptions of gastroenterologists and nurses regarding irritable bowel syndrome and inflammatory bowel disease.
    Dickman R; Segev M; Levi S; Reicher-Atir R; Steinmetz A; Horev N; Niv Y
    Eur J Gastroenterol Hepatol; 2011 Sep; 23(9):813-7. PubMed ID: 21701390
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Relations between symptom severity, illness perceptions, visceral sensitivity, coping strategies and well-being in irritable bowel syndrome guided by the common sense model of illness.
    Knowles SR; Austin DW; Sivanesan S; Tye-Din J; Leung C; Wilson J; Castle D; Kamm MA; Macrae F; Hebbard G
    Psychol Health Med; 2017 Jun; 22(5):524-534. PubMed ID: 27045996
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Measuring health-related quality of life in patients with irritable bowel syndrome: can less be more?
    Lackner JM; Gudleski GD; Zack MM; Katz LA; Powell C; Krasner S; Holmes E; Dorscheimer K
    Psychosom Med; 2006; 68(2):312-20. PubMed ID: 16554399
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Fatigue in patients with primary sclerosing cholangitis.
    Björnsson E; Simren M; Olsson R; Chapman RW
    Scand J Gastroenterol; 2004 Oct; 39(10):961-8. PubMed ID: 15513335
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Illness perceptions mediate the relationship between bowel symptom severity and health-related quality of life in IBS patients.
    De Gucht V
    Qual Life Res; 2015 Aug; 24(8):1845-56. PubMed ID: 25663636
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Natural history and impact of irritable bowel syndrome-type symptoms in inflammatory bowel disease during 12 months of longitudinal follow-up.
    Barberio B; Fairbrass KM; Gracie DJ; Ford AC
    Neurogastroenterol Motil; 2024 Feb; 36(2):e14713. PubMed ID: 37994228
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A comparison of self-perceived health status in inflammatory bowel disease and irritable bowel syndrome patients from a Canadian national population survey.
    Tang LY; Nabalamba A; Graff LA; Bernstein CN
    Can J Gastroenterol; 2008 May; 22(5):475-83. PubMed ID: 18478133
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Symptoms of irritable bowel syndrome in patients with inflammatory bowel disease: examining the role of sub-clinical inflammation and the impact on clinical assessment of disease activity.
    Berrill JW; Green JT; Hood K; Campbell AK
    Aliment Pharmacol Ther; 2013 Jul; 38(1):44-51. PubMed ID: 23668698
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Coping strategies and irrational beliefs as mediators of the health-related quality of life impairments in irritable bowel syndrome.
    Stanculete MF; Matu S; Pojoga C; Dumitrascu DL
    J Gastrointestin Liver Dis; 2015 Jun; 24(2):159-64. PubMed ID: 26114174
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Health-related quality of life, work productivity, and indirect costs among patients with irritable bowel syndrome with diarrhea.
    Buono JL; Carson RT; Flores NM
    Health Qual Life Outcomes; 2017 Feb; 15(1):35. PubMed ID: 28196491
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Stigmatization toward irritable bowel syndrome and inflammatory bowel disease in an online cohort.
    Taft TH; Bedell A; Naftaly J; Keefer L
    Neurogastroenterol Motil; 2017 Feb; 29(2):. PubMed ID: 27501483
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The association of catastrophizing with quality-of-life outcomes in patients with irritable bowel syndrome.
    Sherwin LB; Leary E; Henderson WA
    Qual Life Res; 2017 Aug; 26(8):2161-2170. PubMed ID: 28324323
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Genomic and clinical effects associated with a relaxation response mind-body intervention in patients with irritable bowel syndrome and inflammatory bowel disease.
    Kuo B; Bhasin M; Jacquart J; Scult MA; Slipp L; Riklin EI; Lepoutre V; Comosa N; Norton BA; Dassatti A; Rosenblum J; Thurler AH; Surjanhata BC; Hasheminejad NN; Kagan L; Slawsby E; Rao SR; Macklin EA; Fricchione GL; Benson H; Libermann TA; Korzenik J; Denninger JW
    PLoS One; 2015; 10(4):e0123861. PubMed ID: 25927528
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Quality of life in inflammatory bowel disease in remission: the impact of IBS-like symptoms and associated psychological factors.
    Simrén M; Axelsson J; Gillberg R; Abrahamsson H; Svedlund J; Björnsson ES
    Am J Gastroenterol; 2002 Feb; 97(2):389-96. PubMed ID: 11866278
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Symptom interpretation and quality of life in patients with irritable bowel syndrome.
    Bray BD; Nicol F; Penman ID; Ford MJ
    Br J Gen Pract; 2006 Feb; 56(523):122-6. PubMed ID: 16464326
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 52.